Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05939440 · ClinicalTrials.gov registry record · NA
Interventions to Decrease Financial Toxicity
A NA study of Cervical Cancer and Uterine Cancer, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05939440: Completed NA study of Cervical Cancer and Uterine Cancer, sponsored by University of Alabama at Birmingham.
NCT05939440 is a NA study of Cervical Cancer and Uterine Cancer that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 60 participants, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05939440, a NA study of Cervical Cancer and Uterine Cancer, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Financial distress affects 30-70% of cancer patients and describes the burden that patients experience due to the costs of care (CoC). One reason may be because patients lack the appropriate information on CoC that would help them better plan for and manage their CoC. Therefore, the investigators plan to test a Proactive CoC intervention which includes a discussion with a trained educator on CoC information and a Cost Tracking tool to help patients deal with their CoC.
Primary Outcome
FD measured using the Comprehensive Score for Financial Toxicity (COST) (12 items) The score ranges from 0 to 44 with lower scores indicating worse financial distress. A Score \<26 indicates financial distress is present.
Conditions Studied
Interventions
- OTHER Usual Care
- OTHER Proactive Cost of Care (P-COC) intervention
Study Locations (1)
Alabama
- O'Neal Comprehensive Cancer Center - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
What the finished NCT05939440 record still lists
NCT05939440 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (89% lower).
The record links to 6 conditions, with Cervical Cancer appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT05939440 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05939440 about?
NCT05939440 is a clinical study titled "Interventions to Decrease Financial Toxicity". Financial distress affects 30-70% of cancer patients and describes the burden that patients experience due to the costs of care (CoC). One reason may be because patients lack the appropriate information on CoC that would help them better plan for and manage their CoC. Therefore, the investigators pl...
What is the current status of trial NCT05939440?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-06-01. Estimated completion is 2025-05-31.
What conditions does trial NCT05939440 study?
This clinical trial studies the following conditions: Cervical Cancer, Uterine Cancer, Vulvar Cancer, Cancer, Breast, Cancer - Ovarian.
What interventions are being tested in trial NCT05939440?
The interventions under investigation include: Usual Care (OTHER), Proactive Cost of Care (P-COC) intervention (OTHER).
Who is sponsoring clinical trial NCT05939440?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05939440 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05939440's enrollment target sits among peer trials
60 89th of 144 higher than 53 of 144 other Cervical Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cervical Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI